NewYork-Presbyterian/Columbia Physician has Developed a Potential Nonsurgical Alternative to Mitral Valve Surgery
Nov 8, 2006
Open-heart surgery is a daunting decision for patients at an age. Recently, 88-year-old Nathaniel Grier participated in a groundbreaking clinical trial for a potential alternative to traditional mitral valve surgery. This noninvasive technique enabled him to be treated and released within 48 hours. The procedure could change the way heart patients are treated in the future. With over 700 ongoing clinical trials, NewYork-Presbyterian Hospital and the medical colleges of Weill Cornell and Columbia University collaborate to find answers that enhance and save lives. NewYork-Presbyterian is one of only five hospitals in the country ranked in all 16 specialties reviewed by U.S.News & World Report. To learn more, call 877-NYP-WELL, or visit nyp.org. Don't you deserve this level of care?
- NewYork-Presbyterian/Weill Cornell physician/scientists lead study concluding that current triple-drug regimens effectively treat large majority of HIV patients.
- Columbia researchers discover that a cancer-causing protein stimulates regeneration in nerve cells damaged by neurological disease or spinal cord injury.
- "Camera Pill" may be useful in diagnosing conditions in the esophagus, according to NewYork-Presbyterian/Weill Cornell gastroenterologist.
- NewYork-Presbyterian/Weill Cornell surgeons among first to implant new stents designed for use in delicate brain vessels.
- Protein in nerve cells discovered to be "on/off switch" for chronic pain by Columbia researchers.
- Physicians at NewYork-Presbyterian/Weill Cornell improve removal of stroke-inducing blood clots from brain with use of corkscrew-like device.
- NewYork-Presbyterian/Columbia physician leads clinical trial to maximize effects of biventricular pacemakers and optimize cardiac output in patients with acute heart failure.
- Researchers at NewYork-Presbyterian/Weill Cornell discover that use of IVIg antibodies improves long-term cognitive ability of Alzheimer's patients.
- Prostate cancer drug developed at Weill Cornell demonstrates anti-tumor activity.
- NewYork-Presbyterian/Columbia physicians lead landmark trial demonstrating carotid stenting safe for patients with asymptomatic carotid artery disease.
- NewYork-Presbyterian/Weill Cornell physicians first to test gene therapy as potential treatment for Parkinson's disease.
- New incision-free technique for colorectal cancer surgery pioneered by NewYork-Presbyterian/Weill Cornell surgeons.
- Morgan Stanley Children's Hospital physician/scientist leads international study to find less toxic treatment for children with cancer.
- Genes isolated by Columbia researchers may explain 74% of age-related macular degeneration cases.
- Physicians at NewYork-Presbyterian/Columbia lead study to confirm that noninvasive gene expression testing from routine blood work can detect heart transplant rejection.